ADENOSINE & K/ATP CHANNEL CONTROL OF CORONARY BLOOD FLOW
腺苷
基本信息
- 批准号:3368842
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-05-25 至 1997-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
When cardiac oxygen metabolism increases, as during exercise, there is
a simultaneous increase in coronary blood flow that supplies more oxygen
to the heart. Normally there is a very close match between the increase
in oxygen supply and oxygen demand. How this match occurs is the
fundamental question in coronary physiology. In humans with coronary
artery disease, the oxygen supply is inadequate, and the resulting
myocardial ischemia causes anginal chest pain.
It is postulated that adenosine and/or K+ATP channels (which interact
with adenosine) are involved in the feedback control of coronary blood
flow that normally maintains an adequate oxygen supply to the heart. The
key element in testing the adenosine hypothesis is an estimation of
interstitial adenosine concentration, which cannot be directly measured.
Indicator-dilution experiments will be used to obtain the parameters for
a mathematical model that will then be used to calculate the interstitial
adenosine concentration from coronary blood flow and the venous plasma
adenosine concentration. The role of adenosine will be tested with a
selective adenosine receptor blocking agent, 8-phenyltheophyl-line, and
the role of K+ATP channels with the selective channel blocking agent,
glibenclamide. The use of these blocking agents in combination with
adenosine concentration measurements will critically test the role of
adenosine and/or K+ATP channels in controlling coronary blood flow during
catecholamine stimulation of the heart, cardiac pacing and exercise.
The significance of this research is that the basic mechanism of coronary
control will be studied. An understanding of normal physiological
control is important in itself but is also relevant to pathological
states.
当心脏氧代谢增加时,如在运动时,有
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC O FEIGL其他文献
ERIC O FEIGL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC O FEIGL', 18)}}的其他基金
ADENOSINE & K+ATP CHANNELS IN CORONARY FLOW REGULATION (HL49822)
腺苷
- 批准号:
6119778 - 财政年份:1998
- 资助金额:
$ 23.03万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 23.03万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 23.03万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 23.03万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 23.03万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 23.03万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 23.03万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 23.03万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 23.03万 - 项目类别:














{{item.name}}会员




